← Eichor
Study identifier: NCT04702321 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Genetic Risks for Childhood Cancer Complications in Switzerland

Condition: Childhood Cancer · Genetic Predisposition · Late Effect  ·  Sponsor: University Hospital, Geneva

PhaseN/A
Planned participants6000
Who can joinAll sexes, N/A to 21 Years
Healthy volunteersNo

About this study

The objectives of the GECCOS project are to identify genetic variants associated with complications of childhood cancer using genotype-phenotype association studies. Germline genetic samples and data of the "Germline DNA Biobank for Childhood Cancer and Blood Disorders Switzerland" (BISKIDS) which is included in the Geneva Biobank for Hematology and Oncology in Pediatrics (BaHOP) will be used with clinical data of Swiss childhood cancer patients collected at the Institute of Social and Preventive Medicine in Bern.

This description comes directly from the study's public registry record.

Talk to the study team

Marc Ansari, Prof  ·  +41 79 553 61 00  ·  Marc.Ansari@hcuge.ch

Nicolas Waespe, MD  ·  +41 77 435 37 95  ·  biskids@cansearch.ch

Always discuss trial participation with your own doctor first.

Locations (1)

University Hospital of GenevaGeneva, SwitzerlandRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT04702321